Robotic versus open Frey&apos;s procedure for chronic pancreatitis: a single center&apos;s experience of 40 cases over a 7-year period

Inflammatory Bowel Disease

Cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain long-term drug-free remission in paediatric Crohn's disease (CD-HOPE): an open-label, endpoint-blinded, randomised controlled trial

Lancet Gastroenterol Hepatol

Pigneur B, Martinez-Vinson C, Bourmaud A, Dabadie A, Duclaux-Loras R, Hugot JP, Roman C, Dumant C, Spyckerelle C, Guinard-Samuel V, Willot S, Dupont C, Breton A, Caron N, Chaillou E, Rebouissoux L, Bertrand V, Triolo V, Pages J, Djeddi D, Bonneton M, Uhlen S, Catteau N, Coopman S, Lepage P, Viala J, Ruemmele FM

doi: 10.1016/S2468-1253(25)00262-6

Esophagus DiseasesGastrointestinal Cancer

Comparative effectiveness of the Clutch Cutter versus Dual knife for esophageal endoscopic submucosal dissection by non-expert endoscopists: a single-center retrospective cohort study

BMC Gastroenterol

Terasaki K, Sakai K, Yorioka Y, Kimura H, Fujiishi S, Fujinami M, Watanabe K, Amioka S, Nonaka T, Miura T, Okuda K, Oya H, Katayama T, Fukumoto K, Mitsumoto Y, Mizuno C, Shima T, Okanoue T

doi: 10.1186/s12876-026-04936-w

Inflammatory Bowel Disease

Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial

J Crohns Colitis

Raine T, Danese S, Schreiber S, Gao X, Hanauer S, Torres J, Cunneen C, Kligys K, Huang X, Garrison A, Neimark E, Anschutz T, Crowley J, Cross RK

doi: 10.1093/ecco-jcc/jjag104

Further Publications

EUS-guided drainage for pelvic abscesses: a Chinese single-center two-year follow-up study highlighting clinical outcomes

BMC Gastroenterol

Yang T, Lu Y, Li W, Deng J, Liu T, Liu Y, Zhi M, Sun J

doi: 10.1186/s12876-026-04741-5

Inflammatory Bowel Disease

Real-World Effectiveness of Upadacitinib for Perianal Crohn's Disease: A Multi-Center Retrospective Study

Clin Gastroenterol Hepatol

Devi J, Patel A, Quraishi B, Dev B, Tan T, Kline M, Chowla N, Ramesh PR, Ballard DH, Huang L, Jaiprada F, Samaan S, Stone M, Khan A, Seeraj AA, Alanazi S, Xu A, Maas L, Jajoo A, Parian A, Altinmakas E, Ehman EC, Davenport MS, Li S, Chithriki M, Shukla R, McCurdy J, Yarur AJ, Bishu S, Johnson AM, Benjamin M, Dulaney D, Serre-Yu W, Deepak P

doi: 10.1016/j.cgh.2026.05.003

Inflammatory Bowel Disease

Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study

J Crohns Colitis

Neri B, Schiavone SC, Mancone R, Fiorillo M, Fonsi A, Calabrese E, Perugini L, Piccione G, Di Matteo FM, Marafini I, Lolli E, Sica GS, Monteleone G, Biancone L

doi: 10.1093/ecco-jcc/jjaf163

Inflammatory Bowel Disease

Efficacy and Safety of Risankizumab in Patients with Moderately to Severely Active Crohn's Disease: Interim Results from the SEQUENCE Open-Label Extension Study

J Crohns Colitis

Peyrin-Biroulet L, Atreya R, Danese S, Lindsay JO, Chapman JC, Anschutz T, Huang X, Zambrano J, van Haaren S, Joshi N, Duan WR, Cross RK

doi: 10.1093/ecco-jcc/jjaf213

Inflammatory Bowel Disease

Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study

Lancet Gastroenterol Hepatol

D'Haens GR, Löwenberg M, Baert F, Bossuyt P, Molnár T, Hoentjen F, Clasquin E, Gecse KB, Hulshoff MS, De Hertogh G, Lenfant M, Oldenburg L, Vermeire S

doi: 10.1016/S2468-1253(25)00233-X

Inflammatory Bowel Disease

Mirikizumab Long-Term Efficacy and Safety in Patients with Crohn's disease: Results from the VIVID-2 Open-Label Extension Trial

Clin Gastroenterol Hepatol

Sands BE, Barnes EL, D'Haens G, Hisamatsu T, Regueiro M, Kelly CR, Laharie D, Hozak RR, Yu G, Gandhi R A, Lopes MU, Durand F, Protic M, Moses RE, Vermeire S

doi: 10.1016/j.cgh.2026.01.049

Gastroenterology

Robotic versus open Frey's procedure for chronic pancreatitis: a single center's experience of 40 cases over a 7-year period

Related content

Cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain long-term drug-free remission in paediatric Crohn's disease (CD-HOPE): an open-label, endpoint-blinded, randomised controlled trial

Comparative effectiveness of the Clutch Cutter versus Dual knife for esophageal endoscopic submucosal dissection by non-expert endoscopists: a single-center retrospective cohort study

Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial

EUS-guided drainage for pelvic abscesses: a Chinese single-center two-year follow-up study highlighting clinical outcomes

Real-World Effectiveness of Upadacitinib for Perianal Crohn's Disease: A Multi-Center Retrospective Study

Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study

Efficacy and Safety of Risankizumab in Patients with Moderately to Severely Active Crohn's Disease: Interim Results from the SEQUENCE Open-Label Extension Study

Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study

Mirikizumab Long-Term Efficacy and Safety in Patients with Crohn's disease: Results from the VIVID-2 Open-Label Extension Trial